ArQule To Report First Quarter 2016 Financial Results On

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
ArQule To Report First Quarter 2016 Financial Results On May 4, 2016

BURLINGTON, Mass., April 20, 2016 (GLOBE NEWSWIRE) -- ArQule, Inc. (Nasdaq: ARQL ) today announced it will report financial results for the first quarter 2016 before the market opens on Wednesday, May 4, 2016.  The Company will hold a conference call and webcast on the same day at 9:00 a.m. ET to discuss these results and provide a general business update. 

The live webcast can be accessed in the “Investors & Media” section of our website, www.arqule.com , under “Events & Presentations”. You may also listen to the call by dialing (877) 868-1831 within the U.S. or (914) 495-8595 outside the U.S. A replay will be available two hours after the completion of the call and can be accessed in the “Investors & Media” section of our website, www.arqule.com , under “Events and Presentations”.

About ArQule

ArQule is a biopharmaceutical company engaged in the research and development of targeted therapeutics to treat cancers and rare diseases. Our mission is to discover, develop and commercialize novel small molecule drugs in areas of high unmet need that will dramatically extend and improve the lives of our patients. Our prioritized clinical-stage pipeline consists of four drug candidates, all of which are in targeted, biomarker-defined patient populations, making ArQule a potential early leader in precision medicine. ArQule’s lead product, in phase 3 clinical development, is tivantinib (ARQ 197), an oral, selective inhibitor of the c-MET receptor tyrosine kinase, for second-line treatment of hepatocellular carcinoma in partnership with Daiichi Sankyo in the West and Kyowa Hakko Kirin in Asia. ArQule’s proprietary pipeline includes: ARQ 092, designed to inhibit the AKT serine/threonine kinase, in phase 1 for multiple oncology indications as well as ultra-rare Proteus syndrome, in partnership with the National Institutes of Health (NIH); ARQ 087, a multi-kinase inhibitor designed to preferentially inhibit the fibroblast growth factor receptor (FGFR) family, in phase 2 for iCCA and in phase 1b for multiple oncology indications; and ARQ 761, a β-lapachone analog being evaluated as a promoter of NQO1-mediated programmed cancer cell necrosis, in phase 1/2 in multiple oncology indications in partnership with the University of Texas Southwestern Medical Center. ArQule’s current discovery efforts are focused on the identification and development of novel kinase inhibitors, leveraging the Company’s proprietary library of compounds. 

Contact: Dawn Schottlandt Sr. Director, Investor Relations/ Corp. Communications (781) 994-0300 www.arqule.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 24

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 353

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 265

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 21

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 278

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 550

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 21

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 28

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading

Top 5 Most Recently Viewed Articles

Bank of France's Villeroy Talks About Fiscal Deficit Strategies

Updated Category News Views 84

Bank of France's Perspective on France's Budget Deficit In a recent conversation, Francois Villeroy de Galhau, the head of the Bank of France, addressed the challenges France faces concerning its budget deficit. He pointed out that while hitting a 3% GDP deficit in three years might be unrealistic, there is still a chance for success within five years if the right...

Continue Reading
Vantiva Reports Strong Financial Growth in H1 2025

Updated Category News Views 273

Vantiva Financial Performance Review for H1 2025 Strong EBITDA Growth and Positive Cash Flow Vantiva, known for its significant role in the connectivity sector, has unveiled its financial outcomes for the first half of 2025. The results reflect considerable growth, driven by a strategic transformation plan aimed at enhancing operational efficiency and customer...

Continue Reading
Invisors Achieves 4632 Rank on Inc. 5000 Fastest Growing List

Updated Category News Views 170

Invisors Recognized on the Inc. 5000 List Invisors has achieved remarkable recognition by securing the 4632nd position on the esteemed Inc. 5000 list, celebrating the fastest-growing private companies in America. This achievement marks the fifth time that Invisors has made its way onto this prestigious ranking, reflecting not only the organization's strong revenue growth...

Continue Reading
Invivyd Showcases PEMGARDA™ Advances at IDWeek 2024

Updated Category News Views 395

Invivyd Outlines Significant Findings on PEMGARDA™ at IDWeek 2024 Invivyd, Inc. (Nasdaq: IVVD), a dedicated biopharmaceutical enterprise, is set to present groundbreaking findings related to its investigational monoclonal antibody, pemivibart, at the much-anticipated IDWeek 2024 conference. Here, researchers and healthcare professionals will gather in Los Angeles to...

Continue Reading
Netcompany Reports Strong Results and Future Outlook

Updated Category News Views 637

Continued Growth and Investment in Future Prospects Netcompany has showcased promising performance, particularly in the second quarter of 2025, with a reported revenue growth of 3.9%, totaling DKK 1,714.9 million. This aligns with a steady trajectory that the company has maintained over recent periods, emphasizing its strong market presence and resilience even as it faces...

Continue Reading